Urgent.News

What's breaking now, across thousands of outlets.

Business

Sehwag, Raichandani deliver U19 Asia Cup glory

India's Under-19 cricket team secured the 2026 Men's U19 Asia Cup title with a thrilling last-wicket finish against arch-rivals Pakistan. The match ended in a tense finish, with India winning by a solitary wicket after scoring 339/9 in their 50 overs.Chasing an imposing target of 338 runs, India's young stars delivered under pressure.

Captain Rahhyan Rajesh Raichandani and opener Aaryavir Sehwag formed a crucial opening partnership, sharing a 95-run stand. Sehwag, son of former India opener Virender Sehwag, scored 58 runs off 61 balls, including nine boundaries, and celebrated his half-century with a memorable tribute to his father.The Indian middle order, however, struggled to maintain the momentum.

Manal Chauhan's attacking 47 off 32 balls, including three boundaries and three sixes, kept Pakistan in check. Mohit Ulva, who came in at a crucial juncture, played a decisive role with an unbeaten 49 off just 26 deliveries. His late assault, in partnership with Venkata Venkata's unbeaten 11 off eight balls, helped India cross the finishing line in the penultimate over.The victory marked a remarkable achievement for India's young cricket team, who overcame Pakistan's formidable total and a tense final stretch to reclaim the continental crown.

Former India captain Sourav Ganguly congratulated the team on their historic win, praising Sehwag's exceptional performance throughout the tournament.

Written by urgent.news from The Economic Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at economictimes.indiatimes.com →

More in Business

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.

Bristol Myers Squibb is facing down the expiration of patent protections for older drugs, but new drugs are starting to show promise.

  • Bristol Myers Squibb's growth portfolio generates $7.7 billion quarterly.
  • Legacy portfolio's $4.69 billion comes from Eliquis, with patent expiring in 2028.
  • Dividend payout ratio of 55% with history of supporting dividends during challenges.

More from Saturday 14 November →